NCT02857374View on ClinicalTrials.gov

Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 3, 2016

Primary Completion Date

August 28, 2018

Study Completion Date

June 13, 2022

Conditions
Stage IB Skin MelanomaStage IIA Skin MelanomaStage IIB Skin MelanomaStage IIC Skin MelanomaStage IIIA Skin MelanomaStage IIIB Skin MelanomaStage IIIC Skin Melanoma
Interventions
PROCEDURE

Diagnostic Microscopy

Undergo intravital microscopy

DRUG

Fluorescein Sodium Injection

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

Sentinel Lymph Node Biopsy

Undergo standard of care sentinel node biopsy

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT02857374 - Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy | Biotech Hunter | Biotech Hunter